The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Options for Poliomyelitis Vaccination in the United States: Workshop Summary
11:15
Current Status of IPV
Carlton Meschievitz, Pasteur Mérieux Connaught
12:15 p.m.
LUNCH
Options for Poliomyelitis Vaccination
Chair, Wednesday afternoon session
Russell Alexander, Seattle-King County Health Department
1:15 p.m.
Benefits and Risks: Personal Experiences
March of Dimes Historical Video
John Salamone, Oakton, Virginia
Lenita Schafer, Princeton, Massachusetts
1:40
Oral Poliovirus Vaccine—Benefits, Risks, and What Is Not Known
Peter Wright, Vanderbilt University
2:20
Inactivated Poliovirus Vaccines—Benefits, Risks, and What Is Not Known
Stanley Plotkin, Pasteur Mérieux Connaught
3:00
Sequential Use of IPV and OPV—Benefits, Risks, and What Is Not Known
John Modlin, Dartmouth Medical School
3:50
Parental Choice—Benefits, Risks, and What Is Not Known
Neal Halsey, Johns Hopkins University
4:00
No Vaccine—Benefits, Risks, and What Is Not Known
D. A. Henderson, Johns Hopkins University
4:20
Modelling the Five Options
Robert Kohberger, Lederle-Praxis
Roland Sutter, Centers for Disease Control and Prevention
